Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Biotherapeutic

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Supporting Advanced Biotherapeutic Development

Mass Spectrometry

Supporting Advanced Biotherapeutic Development

Protylix

PAO-05-22-R250-10May 26, 2022

LNC Therapeutics Chooses Luina Bio for the Development and GMP Manufacturing of its First Live Biotherapeutic Product Based on the Gut Microbiome

Microbiome

LNC Therapeutics Chooses Luina Bio for the Development and GMP Manufacturing of its First Live Biotherapeutic Product Based on the Gut Microbiome

LNC Therapeutics

PR-M01-20-NI-009January 06, 2020

Gyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeutics

Biotherapeutics

Gyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeutics

Gyros Protein Technologies

PR-M09-18-NI-010September 05, 2018

Demand for Ovarian Cancer Drugs Forecast to Increase

Pharma

Demand for Ovarian Cancer Drugs Forecast to Increase

Emilie Branch

Pharma's Almanac

PAO-M05-17-NI-005May 05, 2017

A New Type of Medicine: Biotherapeutics Usher in a New Era

A New Type of Medicine: Biotherapeutics Usher in a New Era

Nice Insight

PTV-M11-16-AP-018April 06, 2017

Applying Advanced Protein Engineering Technologies to Biotherapeutic Development

Applying Advanced Protein Engineering Technologies to Biotherapeutic Development

Gjalt Huisman, Ph.D.

Codexis

PAP-Q03-16-CL-009August 01, 2016